{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:41Z","timestamp":1792888541483,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is a worldwide health issue with limited therapies. Traditional Chinese Medicine (TCM) shows potential, but lacks systematic efficacy evaluation and detailed mechanistic explanations. This study aims to evaluate the efficacy of TCM for active UC and explore its mechanisms. A meta-analysis of RCTs was conducted to assess TCM efficacy in active UC, and treatment efficacy was ranked. Core Chinese herbs were identified via association rule analysis. Network pharmacology and molecular docking predicted active components, targets, and pathways. Efficacy of the key component was validated in active UC mice. 17 studies (1,598 patients) showed TCM significantly improved active UC (SMD -1.73, 95%CI -2.21 to -1.25). Eight core Chinese herbs were identified. Network pharmacology revealed 76 overlapping targets. Isorhamnetin (Iso) showed strong binding to PTGS2 (binding energy: -9.34\u00a0kcal\/mol) and Nrf2 (binding energy: -9.16\u00a0kcal\/mol). In vivo, Iso dose-dependently alleviated disease symptoms, pathological damage, and spleen index in UC mice. TCM could ameliorate active UC. The key active component Iso shows therapeutic effects, with mechanisms potentially involving the Nrf2-PTGS2 axis and immune-inflammatory pathways. The findings offer some insight into the scientific basis of TCM in treating UC and predict that Iso may be a candidate for further mechanistic and clinical investigation.<\/jats:p>","DOI":"10.1007\/s00210-026-05737-4","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:49:02Z","timestamp":1784947742000},"page":"21667-21684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation"],"prefix":"10.1007","volume":"399","author":[{"given":"Zhenjia","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"5737_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2468-1253(25)00330-9","volume":"11","author":"R Atreya","year":"2026","unstructured":"Atreya R, Neurath MF (2026) Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis. Lancet Gastroenterol Hepatol 11:5\u20136. https:\/\/doi.org\/10.1016\/S2468-1253(25)00330-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5737_CR2","first-page":"1219","volume":"40","author":"L Bai","year":"2025","unstructured":"Bai L, Li M, An YT (2025) Clinical study on Shenling Baizhu Granules combined with oxalazine in treatment of ulcerative colitis. Drugs Clin Trials 40:1219\u20131223","journal-title":"Drugs Clin Trials"},{"key":"5737_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13020-026-01380-6","volume":"21","author":"YT Cao","year":"2026","unstructured":"Cao YT, Huang X, Yu CL, Wang J, Han X, Wang CW, Luo ZC, Xu WC, Shan JJ, Li YM, Ding K, Zhang Y, Yin AL (2026) Exploring the mechanism of Qinlian Yuyang Decoction in the treatment of ulcerative colitis based on multi-omics technology. Chin Med 21:100. https:\/\/doi.org\/10.1186\/s13020-026-01380-6","journal-title":"Chin Med"},{"key":"5737_CR4","first-page":"34","volume":"53","author":"JL Chen","year":"2021","unstructured":"Chen JL, Shen J, Liu GZ (2021) A clinical study on 30 cases of ulcerative colitis treated with the \u201cYiqi Jiedu Huayu Formula\u201d combined with conventional western medicine. Jiangsu J Tradit Chin Med 53:34\u201337","journal-title":"Jiangsu J Tradit Chin Med"},{"key":"5737_CR5","first-page":"947","volume":"36","author":"L Chen","year":"2021","unstructured":"Chen L, Zhang YQ, Li MR (2021) Clinical study on Jianpi Zhixiening Granules combined with mesalazine in treatment of ulcerative enteritis. Drugs Clin 36:947\u2013951","journal-title":"Drugs Clin"},{"key":"5737_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2026.117865","volume":"248","author":"H Chen","year":"2026","unstructured":"Chen H, Chen S, Huang H, Chen K, Wan H, Zhang R, Wu L, Wu Q, Tong H, Xu G (2026) Kaempferol reprograms pro-inflammatory macrophage polarization by targeting the PTGS2-PGE2 axis: a multi-omics deconvolution of a traditional anti-inflammatory herb pair. Biochem Pharmacol 248:117865. https:\/\/doi.org\/10.1016\/j.bcp.2026.117865","journal-title":"Biochem Pharmacol"},{"key":"5737_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13020-025-01280-1","volume":"21","author":"YJ Chen","year":"2026","unstructured":"Chen YJ, Li CQ, Liu C, Zhu YJ, Wu JJ, Wu TT, Zhu HP, Hua DB, Sun HW (2026) Polydopamine-encapsulated modified Pulsatilla decoction: a strategy to enhance ulcerative colitis therapy. Chin Med 21:2. https:\/\/doi.org\/10.1186\/s13020-025-01280-1","journal-title":"Chin Med"},{"key":"5737_CR8","first-page":"1085","volume":"33","author":"XH Cheng","year":"2018","unstructured":"Cheng XH, Zhang QL, Gong XL (2018) Clinical study on Sishen Pills combined with mesalazine in treatment of ulcerative colitis. Drugs Clin 33:1085\u20131088","journal-title":"Drugs Clin"},{"key":"5737_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s10753-014-9846-9","volume":"37","author":"S Chirumbolo","year":"2014","unstructured":"Chirumbolo S (2014) Anti-inflammatory action of isorhamnetin. Inflammation 37:1200\u20131201. https:\/\/doi.org\/10.1007\/s10753-014-9846-9","journal-title":"Inflammation"},{"key":"5737_CR10","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.2147\/JIR.S520404","volume":"18","author":"X Deng","year":"2025","unstructured":"Deng X, Xie A, Ye D, Ma Y, Bao Z, Xie Q, Luo Z, Wang R, Li H, Yu R (2025) Melatonin activates KEAP1\/NRF2\/PTGS2 pathway to attenuate hyperoxia-driven ferroptosis in bronchopulmonary dysplasia. J Inflamm Res 18:7571\u20137583. https:\/\/doi.org\/10.2147\/JIR.S520404","journal-title":"J Inflamm Res"},{"key":"5737_CR11","doi-asserted-by":"publisher","unstructured":"Dou W, Zhang J, Li H, Kortagere S, Sun K, Ding L, Ren G, Wang Z, Mani S (2014) Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. J Nutr Biochem 25(9):923\u2013933.https:\/\/doi.org\/10.1016\/j.jnutbio.2014.04.006","DOI":"10.1016\/j.jnutbio.2014.04.006"},{"key":"5737_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157627","volume":"150","author":"Z Gai","year":"2026","unstructured":"Gai Z, Wang R, Xiao L, Yan S, Min C, Gong G, Zhao J (2026) Isorhamnetin attenuates lipopolysaccharide-induced myocardial inflammatory injury by inhibiting PPAR\u03b3 and preserving mitochondrial homeostasis. Phytomedicine 150:157627. https:\/\/doi.org\/10.1016\/j.phymed.2025.157627","journal-title":"Phytomedicine"},{"key":"5737_CR13","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1007\/s00210-025-03811-x","volume":"398","author":"T Gangwar","year":"2025","unstructured":"Gangwar T, Poonia N, Subudhi RN, Arora V (2025) Therapeutic potential and underlying mechanisms of phytoconstituents: emphasizing on resveratol, curcumin, quercetin, berberine, and hesperidin in ulcerative colitis. Naunyn Schmiedebergs Arch Pharmacol 398:6579\u20136596. https:\/\/doi.org\/10.1007\/s00210-025-03811-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5737_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041851","volume":"27","author":"Y Gao","year":"2026","unstructured":"Gao Y, Song N, Fu L, Liang Y, Luo X (2026) A novel PPARG R212W variant causes familial partial lipodystrophy type 3: clinical presentation and functional characterization. Int J Mol Sci 27:1851. https:\/\/doi.org\/10.3390\/ijms27041851","journal-title":"Int J Mol Sci"},{"key":"5737_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110301","volume":"128","author":"G Gong","year":"2020","unstructured":"Gong G, Guan YY, Zhang ZL, Rahman K, Wang SJ, Zhou S, Luan X, Zhang H (2020) Isorhamnetin: a review of pharmacological effects. Biomed Pharmacother 128:110301. https:\/\/doi.org\/10.1016\/j.biopha.2020.110301","journal-title":"Biomed Pharmacother"},{"key":"5737_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG (2023) Ulcerative colitis in adults: a review. JAMA 330:951\u2013965. https:\/\/doi.org\/10.1001\/jama.2023.15389","journal-title":"JAMA"},{"key":"5737_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2026.106226","volume":"126","author":"W Gu","year":"2026","unstructured":"Gu W, Wan R, Chen Z, Wang W, Xie S, Hao C, Liu G, Wan M, Gao P (2026) PPAR-\u03b3 suppresses macrophage senescence and allergic airway inflammation through controlling lipid metabolic pathways. EBioMedicine 126:106226. https:\/\/doi.org\/10.1016\/j.ebiom.2026.106226","journal-title":"EBioMedicine"},{"key":"5737_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.157987","volume":"153","author":"Y Guo","year":"2026","unstructured":"Guo Y, Xu X, Han A, Song F, Zhang Y, Jiang X, Yu W (2026) Isorhamnetin alleviates diet induced MASLD in mice by modulating gut microbiota and bile acid metabolism. Phytomedicine 153:157987. https:\/\/doi.org\/10.1016\/j.phymed.2026.157987","journal-title":"Phytomedicine"},{"key":"5737_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2026.121350","volume":"362","author":"L He","year":"2026","unstructured":"He L, Zhong Z, Liu F, Wen S (2026) Berberine alleviates DSS-induced colitis by modulating macrophage phenotype via PPAR-\u03b3\/mTOR\/HIF-1\u03b1 signaling pathway. J Ethnopharmacol 362:121350. https:\/\/doi.org\/10.1016\/j.jep.2026.121350","journal-title":"J Ethnopharmacol"},{"key":"5737_CR20","first-page":"589","volume":"30","author":"XJ Hu","year":"2024","unstructured":"Hu XJ, Cheng GB, Yao WJ (2024) Clinical efficacy study of Qingre Huashi Yuyang formula combined with mesalazine enteric-coated tablets in the treatment of damp-heat ulcerative colitis of large intestine: a randomized clinical trial. J Colorectal Anal Surg 30:589\u2013594","journal-title":"J Colorectal Anal Surg"},{"key":"5737_CR21","first-page":"69","volume":"34","author":"YZ Huang","year":"2025","unstructured":"Huang YZ, Liu WL, Wu H (2025) A randomized, double-blind, placebo-controlled trial of Jianpi Lishi Jiedu mixture for ulcerative colitis with spleen deficiency and dampness-toxin syndrome. Mod J Integr Tradit Chin West Med 34:69\u201373","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"5737_CR22","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/ibd\/izaf057","volume":"31","author":"M Jiang","year":"2025","unstructured":"Jiang M, Jia Y, Ma C, Zeng Z, Wu Y, Gan H, Zhang H (2025) Akkermansia muciniphila protects against trinitrobenzene sulfonic acid induced colitis by inhibiting IL6\/STAT3 pathway. Inflamm Bowel Dis 31:2217\u20132230. https:\/\/doi.org\/10.1093\/ibd\/izaf057","journal-title":"Inflamm Bowel Dis"},{"key":"5737_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117691","volume":"324","author":"J Kong","year":"2024","unstructured":"Kong J, Xiang Q, Ge W, Wang Y, Xu F, Shi G (2024) Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis. J Ethnopharmacol 324:117691. https:\/\/doi.org\/10.1016\/j.jep.2023.117691","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"5737_CR24","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1039\/d4fo04867a","volume":"16","author":"X Kong","year":"2025","unstructured":"Kong X, Zhao L, Huang H, Kang Q, Lu J, Zhu J (2025) Isorhamnetin ameliorates hyperuricemia by regulating uric acid metabolism and alleviates renal inflammation through the PI3K\/AKT\/NF-\u03baB signaling pathway. Food Funct 16(7):2840\u20132856. https:\/\/doi.org\/10.1039\/d4fo04867a","journal-title":"Food Funct"},{"key":"5737_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L (2023) Ulcerative colitis. Lancet 402:571\u2013584. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2","journal-title":"Lancet"},{"key":"5737_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114444","volume":"152","author":"N Li","year":"2025","unstructured":"Li N, Shang X, Shi L (2025) Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: multi-center, randomized, controlled trials. Int Immunopharmacol 152:114444. https:\/\/doi.org\/10.1016\/j.intimp.2025.114444","journal-title":"Int Immunopharmacol"},{"key":"5737_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.157839","volume":"153","author":"LY Lin","year":"2026","unstructured":"Lin LY, Li HZ, Liu XQ, Xiong S, Li MM, Zhang HY, Qian CW, Liu Z (2026) Isodeoxyelephantopin mitigates DSS-induced ulcerative colitis by suppressing IL-1\u03b2-driven inflammation via the TXNIP\/NLRP3 axis. Phytomedicine 153:157839. https:\/\/doi.org\/10.1016\/j.phymed.2026.157839","journal-title":"Phytomedicine"},{"key":"5737_CR28","first-page":"413","volume":"28","author":"H Liu","year":"2020","unstructured":"Liu H, Huo YL, Hou ZL (2020) Clinical study of Wenglian Jiedu decoction combined with mesalazine in the treatment of ulcerative colitis. Chin J Integr Tradit West Med Dig 28:413\u2013416","journal-title":"Chin J Integr Tradit West Med Dig"},{"key":"5737_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116722","volume":"175","author":"D Long","year":"2024","unstructured":"Long D, Mao C, Huang Y, Xu Y, Zhu Y (2024) Ferroptosis in ulcerative colitis: potential mechanisms and promising therapeutic targets. Biomed Pharmacother 175:116722. https:\/\/doi.org\/10.1016\/j.biopha.2024.116722","journal-title":"Biomed Pharmacother"},{"key":"5737_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1425251","volume":"15","author":"D Long","year":"2024","unstructured":"Long D, Mao C, Xu Y, Zhu Y (2024) The emerging role of neutrophil extracellular traps in ulcerative colitis. Front Immunol 15:1425251. https:\/\/doi.org\/10.3389\/fimmu.2024.1425251","journal-title":"Front Immunol"},{"key":"5737_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157153","volume":"146","author":"J Lv","year":"2025","unstructured":"Lv J, Fu Y, Huang S, Han C, Zhang S, Zhang Y, Ga Y, Dai C, Hao Z (2025) Lianweng formula restores intestinal barrier function in ulcerative colitis through the \u03b2-arrestin 1\/NF-\u03baB signaling axis. Phytomedicine 146:157153. https:\/\/doi.org\/10.1016\/j.phymed.2025.157153","journal-title":"Phytomedicine"},{"key":"5737_CR32","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/13880209.2022.2070220","volume":"60","author":"X Mo","year":"2022","unstructured":"Mo X, Tang K, Deng L, Zhou X, Li X, Zhang Y, Wang J (2022) Prevention of ulcerative colitis by Huangqin decoction: reducing the intestinal epithelial cell apoptosis rate through the IFN-\u03b3\/JAK\/ETS signalling pathway. Pharm Biol 60:1116\u20131125. https:\/\/doi.org\/10.1080\/13880209.2022.2070220","journal-title":"Pharm Biol"},{"key":"5737_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.gastro.2017.11.024","volume":"154","author":"M Naganuma","year":"2018","unstructured":"Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, INDIGO Study Group (2018) Efficacy of Indigo Naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology 154:935\u2013947. https:\/\/doi.org\/10.1053\/j.gastro.2017.11.024","journal-title":"Gastroenterology"},{"key":"5737_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N, Ikawa Y (2022) The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 21:103017. https:\/\/doi.org\/10.1016\/j.autrev.2021.103017","journal-title":"Autoimmun Rev"},{"key":"5737_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5737_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161625","volume":"14","author":"DD Ren","year":"2023","unstructured":"Ren DD, Chen KC, Li SS, Zhang YT, Li ZM, Liu S, Sun YS (2023) Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium. Front Immunol 14:1161625. https:\/\/doi.org\/10.3389\/fimmu.2023.1161625","journal-title":"Front Immunol"},{"key":"5737_CR37","doi-asserted-by":"publisher","first-page":"112318","DOI":"10.1016\/j.intimp.2024.112318","volume":"135","author":"Y Ru","year":"2024","unstructured":"Ru Y, Luo Y, Liu D, Huang Q, Zhou X, Linghu M, Luo X, Lv Z, Wu Y, Zhang H, Huang Y (2024) Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2\/HO-1 pathway and chelating iron. Int Immunopharmacol 135:112318. https:\/\/doi.org\/10.1016\/j.intimp.2024.112318","journal-title":"Int Immunopharmacol"},{"key":"5737_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ajg.2012.340","volume":"108","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn WJ, Targan SR, Byers VS, Rutty DA, Mu H, Zhang X, Tang T (2013) Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol 108:90\u201398. https:\/\/doi.org\/10.1038\/ajg.2012.340","journal-title":"Am J Gastroenterol"},{"key":"5737_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102346","volume":"35","author":"J Shen","year":"2025","unstructured":"Shen J, Jiao W, Zhang Y, Zhuang B, Zhang S, Huang G, Ma L, Yang J, Wu Y, Du L, Jin Y (2025) A ROS-responsive nanocarrier co-delivering cerium nanozymes and thalidomide for synergistic ulcerative colitis therapy. Mater Today Bio 35:102346. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102346","journal-title":"Mater Today Bio"},{"key":"5737_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115640","volume":"298","author":"G Shi","year":"2022","unstructured":"Shi G, Kong J, Wang Y, Xuan Z, Xu F (2022) Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-\u03baB signaling pathways and modulating intestinal microbiota. J Ethnopharmacol 298:115640. https:\/\/doi.org\/10.1016\/j.jep.2022.115640","journal-title":"J Ethnopharmacol"},{"key":"5737_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1053\/j.gastro.2024.10.001","volume":"167","author":"S Singh","year":"2024","unstructured":"Singh S, Loftus EV Jr, Limketkai BN, Haydek JP, Agrawal M, Scott FI, Ananthakrishnan AN, AGA Clinical Guidelines Committee (2024) AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis. Gastroenterology 167:1307\u20131343. https:\/\/doi.org\/10.1053\/j.gastro.2024.10.001","journal-title":"Gastroenterology"},{"key":"5737_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1375781","volume":"15","author":"S Su","year":"2024","unstructured":"Su S, Liu T, Zheng JY, Wu HC, Keng VW, Zhang SJ, Li XX (2024) Huang Lian Jie Du decoction attenuated colitis via suppressing the macrophage Csf1r\/Src pathway and modulating gut microbiota. Front Immunol 15:1375781. https:\/\/doi.org\/10.3389\/fimmu.2024.1375781","journal-title":"Front Immunol"},{"key":"5737_CR43","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.11569\/wcjd.v26.i32.1879","volume":"26","author":"YW Sun","year":"2018","unstructured":"Sun YW, Zhang L (2018) Effect of liquorice decoction combined with mesalazine on serum inflammatory factors and T lymphocyte levels in patients with ulcerative colitis. World Chin J Dig 26:1879\u20131885","journal-title":"World Chin J Dig"},{"key":"5737_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1574548","volume":"16","author":"H Tang","year":"2025","unstructured":"Tang H, Fan Q, Lu Y, Lin X, Lan R, Hu D, Zhang S, Wang R, Zhao R, Liu L, Xu J (2025) Weissella confusa alleviates experimental colitis in mice by regulating inflammatory pathways and gut microbiota. Front Microbiol 16:1574548. https:\/\/doi.org\/10.3389\/fmicb.2025.1574548","journal-title":"Front Microbiol"},{"key":"5737_CR45","first-page":"1165","volume":"30","author":"XM Wan","year":"2023","unstructured":"Wan XM, Xie ZY, Zeng JH (2023) Efficacy of Sishen pill compound combined with mesalazine in the treatment of mild to moderate ulcerative colitis and its effect on the circadian rhythm of symptoms. Chin J Prim Med Pharm 30:1165\u20131169","journal-title":"Chin J Prim Med Pharm"},{"key":"5737_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137450","volume":"283","author":"J Wan","year":"2024","unstructured":"Wan J, Wang F, Xiao Y, Cheng Y, Zheng S, Jiang Q, Tan B, Li X, Chen J, Liao S (2024) Poria cocos polysaccharide alleviates dextran sulphate sodium-induced ulcerative colitis in mice by modulating intestinal inflammatory responses and microbial dysbiosis. Int J Biol Macromol 283:137450. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137450","journal-title":"Int J Biol Macromol"},{"key":"5737_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1432816","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu X, Liang Y, Li X, Wang Y, Li J (2022) Sishen Wan treats ulcerative colitis in rats by regulating gut microbiota and restoring the Treg\/Th17 balance. Evid Based Complement Altern Med 2022:1432816. https:\/\/doi.org\/10.1155\/2022\/1432816","journal-title":"Evid Based Complement Altern Med"},{"key":"5737_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2023.12.010","volume":"212","author":"L Wang","year":"2024","unstructured":"Wang L, Xie Y, Xiao B, He X, Ying G, Zha H, Yang C, Jin X, Li G, Ping L, Wang J, Weng Q (2024) Isorhamnetin alleviates cisplatin-induced acute kidney injury via enhancing fatty acid oxidation. Free Radic Biol Med 212:22\u201333. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.12.010","journal-title":"Free Radic Biol Med"},{"key":"5737_CR49","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A (2024) Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci 45:892\u2013903. https:\/\/doi.org\/10.1016\/j.tips.2024.08.003","journal-title":"Trends Pharmacol Sci"},{"key":"5737_CR50","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/life12122107","volume":"12","author":"CS Wu","year":"2022","unstructured":"Wu CS, Lin CC, Chen YY, Yang DH (2022) Mechanisms and effects of isorhamnetin on imiquimod-induced psoriasiform dermatitis in mice. Life (Basel) 12:2107. https:\/\/doi.org\/10.3390\/life12122107","journal-title":"Life (Basel)"},{"key":"5737_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/ibd\/izab348","volume":"28","author":"X Wu","year":"2022","unstructured":"Wu X, Chen H, Gao X, Gao H, He Q, Li G, Yao J, Liu Z (2022) Natural herbal remedy Wumei Decoction ameliorates intestinal mucosal inflammation by inhibiting Th1\/Th17 cell differentiation and maintaining microbial homeostasis. Inflamm Bowel Dis 28:1061\u20131071. https:\/\/doi.org\/10.1093\/ibd\/izab348","journal-title":"Inflamm Bowel Dis"},{"key":"5737_CR52","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1053\/j.gastro.2025.03.039","volume":"169","author":"X Wu","year":"2025","unstructured":"Wu X, Li Y, Li P, Lu G, Wu J, Wang Z, Wen Q, Cui B, Wang J, Zhang F (2025) Structural variations in ulcerative colitis-associated Escherichia coli reduce fructose utilization and aggravate inflammation under high-fructose diet. Gastroenterology 169:909\u2013924. https:\/\/doi.org\/10.1053\/j.gastro.2025.03.039","journal-title":"Gastroenterology"},{"key":"5737_CR53","first-page":"86","volume":"27","author":"LL Xi","year":"2021","unstructured":"Xi LL, Song TP, Shi MH (2021) Clinical study on the treatment of ulcerative colitis of spleen and kidney yang deficiency syndrome with modified Buyang Zhixie Decoction. Guid J Tradit Chin Med Pharm 27:86\u201389","journal-title":"Guid J Tradit Chin Med Pharm"},{"key":"5737_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145906","volume":"320","author":"C Xie","year":"2025","unstructured":"Xie C, Yue J, Li Y, Zhang X, An S, Chen J, Tong J, Wang R, Xie Y, Lu M, Chen J, Wang T, Wu L, He W, Chen G, Yu C (2025) A novel triazole derivative ameliorates ulcerative colitis by targeting PPAR gamma. Int J Biol Macromol 320:145906. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145906","journal-title":"Int J Biol Macromol"},{"key":"5737_CR55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v32.i5.113024","volume":"32","author":"T Xu","year":"2026","unstructured":"Xu T, Hou WX, Yang ST, Shao YP, Wang J, Han TT, Li JN (2026) Danggui-Baishao herb pair protects against dextran sulfate sodium-induced colitis by modulating the Wnt\/\u03b2-catenin pathway. World J Gastroenterol 32:113024. https:\/\/doi.org\/10.3748\/wjg.v32.i5.113024","journal-title":"World J Gastroenterol"},{"key":"5737_CR56","first-page":"39","volume":"57","author":"Q Yang","year":"2025","unstructured":"Yang Q, Hu D (2025) Clinical study on Huangqin Shaoyao Decoction combined with mesalazine sustained release tablets for ulcerative colitis of spleen deficiency and dampness accumulation type. New Chin Med 57:39\u201343","journal-title":"New Chin Med"},{"key":"5737_CR57","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1038\/s41598-024-57852-y","volume":"14","author":"X Yang","year":"2024","unstructured":"Yang X, Wang H, Shen C, Dong X, Li J, Liu J (2024) Effects of isorhamnetin on liver injury in heat stroke-affected rats under dry-heat environments via oxidative stress and inflammatory response. Sci Rep 14:7476. https:\/\/doi.org\/10.1038\/s41598-024-57852-y","journal-title":"Sci Rep"},{"key":"5737_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05296-8","author":"Z Yang","year":"2026","unstructured":"Yang Z, Lu H, Xu S, Xiao G, Hu X (2026) Integrating transcriptomics, network pharmacology, and GraphBAN neural networks to identify biomarkers and regulatory mechanisms of classical traditional Chinese medicine formulations in ulcerative colitis. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05296-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5737_CR59","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1142\/S0192415X24500885","volume":"52","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhu M, Dai Y, Gao L, Cheng L (2024) Research progress in ulcerative colitis: the role of traditional Chinese medicine on gut microbiota and signaling pathways. Am J Chin Med 52:2277\u20132336. https:\/\/doi.org\/10.1142\/S0192415X24500885","journal-title":"Am J Chin Med"},{"key":"5737_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119384","volume":"342","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Feng T, Chang Q, Yang D, Li Y, Shang Y, Gao W, Zhao J, Li X, Ma L, Liang Z (2025) Exploring the potential active components and mechanisms of Tetrastigma hemsleyanum against ulcerative colitis based on network pharmacology in LPS-induced RAW264.7 cells. J Ethnopharmacol 342:119384. https:\/\/doi.org\/10.1016\/j.jep.2025.119384","journal-title":"J Ethnopharmacol"},{"key":"5737_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13020-026-01382-4","volume":"21","author":"JX Zhang","year":"2026","unstructured":"Zhang JX, Dong SQ, Hu YX, Ning HJ, Su QQ, Sun JH, Lin YN, Ke XQ, Li Y, Zhang Y, Chen FL, Wu ZY, Zhou FH, Liu CS (2026) Ethanol extract of Astragali Radix inhibits M1 macrophage polarization to alleviate ulcerative colitis by promoting Lactobacillus reuteri-produced indole-3-carboxaldehyde and formononetin. Chin Med 21:99. https:\/\/doi.org\/10.1186\/s13020-026-01382-4","journal-title":"Chin Med"},{"key":"5737_CR62","first-page":"96","volume":"27","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang DF, Su XL (2021) Clinical study on Qingre Jianpi Decoction combined with mesalazine in the treatment of ulcerative colitis with large intestine damp-heat syndrome. Guid J Tradit Chin Med Pharm 27:96\u201399","journal-title":"Guid J Tradit Chin Med Pharm"},{"key":"5737_CR63","first-page":"906","volume":"32","author":"HX Zhou","year":"2024","unstructured":"Zhou HX, Chen M, Qin HW (2024) Clinical observation of Qingre Huashi Granules in the treatment of ulcerative colitis with damp-heat syndrome: a randomized, prospective, double-blind clinical trial. Chin J Integr Tradit West Med Dig 32:906\u2013909","journal-title":"Chin J Integr Tradit West Med Dig"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:01:53Z","timestamp":1792886513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":63,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5737"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05737-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Animal Ethics Committee of the Beijing Institute of Chinese Medicine (No. BJTCM-M-2025\u201311-05).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}